OTC · INLB
Item 9 Labs Corp.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Sep 18, 2026, 7:06 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 70.18K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.00
- Volume
- 400
- Avg. volume
- 23.59K
Price performance
INLB price history
1M range · 1 trading sessions · Daily adjusted prices
INLB closed at $0.00 after 1 trading sessions, up 0.00% for the selected period.
No results
At least two price observations are needed to draw this chart.
Latest INLB news
The latest Smart Investors Daily articles mentioning INLB.
Stock researchCompany · Overview
INLB research
Overview
Company profile and research snapshot.
Company profile
ITEM 9 LABS CORP
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 22, 2021 | Noble Capital Markets | Outperform | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
